Press Announcements
Note: Press announcements from 2004 to 2015 are available through the FDA.gov Archive. Some links in press announcements may no longer be active. For more information, contact FDA’s Office of Media Affairs at 301-796-4540.
Sign up to receive FDA Press Releases.
May 2018
- May 23, 2018 - FDA takes action against the use of OTC benzocaine teething products due to serious safety risk, lack of benefit
- May 22, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on new FDA actions to keep consumers safe from the harmful effects of sun exposure, and ensure the long-term safety and benefits of sunscreens
- May 22, 2018 - FDA warns companies selling illegal, unapproved kratom products marketed for opioid cessation, pain treatment and other medical uses
- May 21, 2018 - FDA approves new drug for patients with chronic liver disease who have low blood platelets and are undergoing a medical procedure
- May 17, 2018 - FDA approves novel preventive treatment for migraine
- May 17, 2018 - FDA requires additional e-cigarette makers to provide critical information so the agency can better examine youth use and product appeal, amid continued concerns around youth access to products
- May 17, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency efforts to shine light on situations where drug makers may be pursuing gaming tactics to delay generic competition
- May 16, 2018 - FDA approves the first non-opioid treatment for management of opioid withdrawal symptoms in adults
- May 15, 2018 - FDA approves first epoetin alfa biosimilar for the treatment of anemia
- May 11, 2018 - FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients
- May 11, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on the Trump Administration’s plan to lower drug prices
- May 10, 2018 - FDA warns more companies to stop misleading kids with e-liquids that resemble kid-friendly foods as part of Youth Tobacco Prevention Plan
- May 09, 2018 - FDA seeks permanent injunctions against two stem cell clinics
- May 07, 2018 - FDA permits marketing of new endoscopic device for treating gastrointestinal bleeding
- May 07, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on the public health benefits from enactment of menu labeling
- May 04, 2018 - FDA approves new uses for two drugs administered together for the treatment of BRAF-positive anaplastic thyroid cancer
- May 01, 2018 - FDA, FTC take action against companies misleading kids with e-liquids that resemble children’s juice boxes, candies and cookies
April 2018
- April 24, 2018 - Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for testimony before a U.S. Senate Committee on Appropriations on FDA’s Fiscal Year 2019 budget
- April 24, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on new enforcement actions and a Youth Tobacco Prevention Plan to stop youth use of, and access to, JUUL and other e-cigarettes
- April 20, 2018 - FDA authorizes new use of test, first to identify the emerging pathogen Candida auris
- April 20, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to encourage more widespread innovation and development of new treatments for opioid use disorder
- April 20, 2018 - FDA takes new steps to advance the development of innovative products for treating opioid use disorder
- April 19, 2018 - Federal judge enters consent decree against Cantrell Drug Company
- April 17, 2018 - Remarks from FDA Commissioner Scott Gottlieb, M.D. on Fiscal Year 2019 budget request for FDA
- April 17, 2018 - FDA approves first therapy for rare inherited form of rickets, x-linked hypophosphatemia
- April 17, 2018 - Statement by Dr. Susan Mayne on FDA efforts to reduce consumer exposure to arsenic in rice
- April 17, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to enhance and modernize the FDA’s approach to medical device safety and innovation
- April 13, 2018 - FDA takes step to protect consumers against dietary supplements containing dangerously high levels of extremely concentrated or pure caffeine
- April 12, 2018 - FDA finalizes guidances to accelerate the development of reliable, beneficial next generation sequencing-based tests
- April 11, 2018 - FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems
- April 10, 2018 - FDA clears first contact lens with light-adaptive technology
- April 09, 2018 - FDA restricts sale and distribution of Essure to protect women and to require that patients receive risk information
- April 03, 2018 - FDA orders mandatory recall for kratom products due to risk of salmonella
- April 02, 2018 - New York raw milk cheese company ordered to stop sales for food safety violations
March 2018
- March 30, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s efforts to enhance the patient perspective and experience in drug development and review
- March 29, 2018 - FDA expands approval of Blincyto for treatment of a type of leukemia in patients who have a certain risk factor for relapse
- March 29, 2018 - Federal judge approves consent decree with New York dietary supplement manufacturer Riddhi USA
- March 28, 2018 - Federal judge approves consent decree with Florida company that sold unapproved new drugs and misbranded drugs
- March 27, 2018 - FDA authorizes first fully interoperable continuous glucose monitoring system, streamlines review pathway for similar devices
- March 23, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on a key step in advancing FDA’s oversight of drug compounding and implementing new laws governing outsourcing facilities
- March 22, 2018 - Statement from FDA’s Donald St. Pierre on findings from ongoing investigation into lead testing issues
- March 20, 2018 - FDA expands approval of Adcetris for first-line treatment of Stage III or IV classical Hodgkin lymphoma in combination with chemotherapy
- March 20, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on efforts to reduce tobacco use, especially among youth, by exploring options to address the role of flavors ‒ including menthol ‒ in tobacco products
- March 15, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on pivotal public health step to dramatically reduce smoking rates by lowering nicotine in combustible cigarettes to minimally or non-addictive levels
- March 09, 2018 - FDA warns duodenoscope manufacturers about failure to comply with required postmarket surveillance studies to assess contamination risk
- March 08, 2018 - Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for oral testimony before the U.S. House Committee on Energy and Commerce Subcommittee on Oversight and Investigations hearing “Examining U.S. Public Health Preparedness for and Response Efforts to Seasonal Influenza.”
- March 08, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on effort to help bolster U.S. shellfish market by taking mutually beneficial steps to resume shellfish trade with the EU
- March 07, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA activities related to the ongoing post-market review of Essure and FDA’s commitment to keep women informed
- March 06, 2018 - FDA approves first tests to screen for tickborne parasite in whole blood and plasma to protect the U.S. blood supply
- March 06, 2018 - FDA expands approval of replacement heart valve, smallest mechanical valve size approved in the world